Bacterial Translocation

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 26, Issue 3, 2004, Pages 229-235

  Bellhorn, Ted ^a   Macintire, Douglass K ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 1842732928     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Deitch EA, Rutan R, Waymack JP: Trauma, shock and gut translocation. N Horizons 4:289-299, 1996.
2. Deitch EA: Multiple organ failure. Ann Surg 216:117-134, 1992.
3. Kim PK, Deutschman CS: Inflammatory responses and mediators. Surg Clin North Am 80(3):885-894, 2000.
4. Grotz MRW, Deitch EA, Ding J, et al: Intestinal cytokine response after gut ischemia: Role of gut barrier failure. Ann Surg 229(4):478-486, 1999.
5. Moore FA, Moore EE, Poggetti R, et al: Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 31:629-638, 1991.
6. Sedman PC, Macfie J, Sagar P, et al: The prevalence of gut translocation in humans. Gastroenterology 107:643-649, 1994.
7. Reidy JJ, Ramsay G: Clinical trials of selective decontamination of the digestive tract: Review. Crit Care Med 18:1449-1456, 1990.
8. Lemaire LCJM, van Lanschot JJB, Stoutenbeck CP, et al: Bacterial translocation in multiple organ failure: Cause or epiphenomenon still unproven. Br J Surg 84:1340-1350, 1997.
9. Deitch EA, Xu D, Franko L, et al: Evidence favoring the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1:141-145, 1994.
10. Magnotti LJ, Upperman JS, Xu DZ, et al: Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 228:518-527, 1998.
11. Deitch EA: Role of the gut lymphatic system in multiple organ failure. Curr Opinion Crit Care 7(2):92-98, 2001.
12. Deitch EA, Maejima K, Berg R: Effects of oral antibiotics and bacterial over-growth on the translocation of the GI-tract microflora in burned rats. J Trauma 25:385-392, 1985.
13. O'Dwyer ST, Mitchie HR, Ziegler TR, et al: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 123:1459-1464, 1988.
14. Endo S, Katsuya I, Yamada Y, et al: Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 22:949-955, 1994.
15. Baue AE: Predicting outcome in injured patients and its relationship to circulating cytokines. Shock 4:39-40, 1995.
16. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases, Crit Care Med 21:5423-5435, 1993.
17. Marino PL: Oxidant injury, in Wingfield WE, Raffe MR (eds): The Veterinary ICU Book. Jackson Hole, WY, Teton New Media, 2002, p 28.
18. Nadlet EP, Ford HR: Regulation of bacterial translocation by nitric oxide. Ped Surg Int 16(3):165-168, 2000.
19. Andrejko KM, Deutchman CS: Acute-phase gene expression correlates with intrahepatic tumor necrosis factor-α (abundance but not plasma TNF levels during sepsis/SIRS in the rat). Crit Care Med 24:1947-1952, 1996.
20. Andrejko KM, Deutchman CS: Altered hepatic gene expression in fecal peritonitis: Changes in transcription of gluconeogenic, β-oxidative, and ureagenic genes. Shock 7:164-167, 1997.
21. Tani T, Mitschiro F, Kazuyoshi H, et al: Bacterial translocation and tumor necrosis factor-α gene expression in hemorrhagic shock. Crit Care Med 28(11):3705-3709, 2000.
22. Ljungdahl M, Lundholm M, Katouli M, et al: Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora. Scand J Gastroenterol 35(4):389-397, 2000.
23. Guiney DG: Regulation of bacterial virulence gene expression by the host environment. J Clin Invest 99(4):565-569, 1997.
24. Alverdy J, Holbrook C, Rocha F, et al: Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: Evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg 232(4): 480-489, 2000.
25. MacFie J, O'Boyle C, Mitchell CJ, et al: Gut origin of sepsis: A prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45(2):223-228, 1999.
26. Yang CY, Chang CS, Chen GH: Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol 33(8):867-871, 1998.
27. Chang CS, Chen GH, Lien HC, Yeh HZ: Small intestinal dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 28(5):1187-1190, 1998.
28. Savage DC, Dubos R, Schaedler RW: The gastrointestinal epithelium and its autochthonous bacterial flora. J Exp Med 127:67-72, 1968.
29. Macintire DK: Bacterial translocation: Clinical implication and prevention, in Bonagura JD (ed): Kirk's Current Veterinary Therapy XIII. Philadelphia, WB Blunders, 2000, p 201.
30. Haskel Y, Udassin R, Freund HR, et al: Liquid enteral diets induce bacterial translocation by increasing cecal flora without changing intestinal motility. J Parent Enteral Nutr 25(2):60-64, 2001.
31. Speath G, Berg CP, Specian RD, et al: Food without fiber promotes bacterial translocation from the gut. Surg 108:240-247, 1990.
32. Keith ME, Jeejeebhoy KN: Enteral nutrition. Curr Opinion Gastroenterol 14: 151-156, 1998.
33. Foitzik T, Kruschewski M, Kroesen AJ, et al: Does glutamine reduce bacterial translocation? A study in two animal models with impaired gut barrier. Int J Colorectal Dis 14(3):143-149, 1999.
34. Hwang TL, O'Dwyer ST, Smith RJ, et al: Presentation of small bowel mucosa using glutamine-enriched patenteral nutrition. Surg Forum 37:56-59, 1986.
35. Burke D, Alverdy JC, Aoys E, et al: Glutamine supplemented TPN improves gut immune function. Arch Surg 124:1396-1399, 1989.
36. Marks SL, Cook AK, Reader R, et al: Effects of glutamine supplementation of an amino acid-based purified diet on intestinal mucosal integrity in cats with methotrexate-induced enteritis. Am J Vet Res 60(6):755-763, 1999.
37. th ACVIM Forum:430-431, 1998.
38. Gennari R, Alexander JW: Effects of hyperoxia on bacterial translocation and mortality during gut-derived sepsis. Arch Surg 131:57-62, 1996.
39. Tani T, Fujino M, Hanasawa K, et al: Bacterial translocation and tumor necrosis factor-α gene expression in experimental hemorrhagic shock. Crit Care Med 28(11);3705-3709, 2000.
40. Silverman HJ, Tuma P: Gasttic tonometry in patients with sepsis: Effects of dobutamine and packed red blood cell transfusions. Chest 102:184-191, 1992.
41. Assalia A, Bitterman H, Hirsh TM, Krausz MM: Influence of hypertonic saline on bacterial translocation in controlled hemorrhagic shock. Shock 15(4):307-311, 2001.
42. Yada-Langui MM, Coimbra R, Lancellotti C, et al: Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after hemorrhagic shock. Shock 14(6):594-598, 2000.
43. Ciesla DJ, Moore EE, Gonzalez RJ, et al: Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock 14(3): 265-270, 2000.
44. Murao Y, Hoyt DB, Loomis W, et al: Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage? Shock 14(1):18-23, 2000.
45. Kaplan SS, Park TS, Gonzales ER, Gidday JM: Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke 31(9):2218-2223, 2000.
46. Brady CA, Otto CM: Systemic inflammatory response syndrome, sepsis, and multiple organ disfunction. Vet Clin North Am Small Anim Prac 31(6):1147-1161, 2001.
47. Krueger WA, Unertt KE: Selective decontamination of the digestive tract; Review. Curr Opin Crit Care 8(2):139-144, 2002.
48. Chaing CH, Wu CP, Perng WC, et al: Dexamethasone and pentastarch additive attenuation of ischemia/reperfusion lung injury. Clin Sci 99(5):413-419, 2000.
49. Poggetti RS, Moore FA, Moore EE, et al: Simultaneous liver and lung injury following gut ischemia is mediated by xanthine oxidase. J Trauma 32:723-728, 1992.
50. Marzi I, Buhren V, Schuttler A, et al: Value of Superoxide dismutase for prevention of multiple organ failure after multiple trauma. J Trauma 35:110-119, 1993.
51. Hallaway PE, Eaton JW, Panter SS, et al: Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci USA 88:10108-10112, 1989.
52. Bauer C, Walchar F, Holanda M, et al: Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock. J Trauma 46:886-893, 1999.
53. Harada H, Ishizaka, Yoramuru M, et al: The effects of aminophylline and pentoxifylline on multiple organ damage after E. coli sepsis. Am Rev Rispir Dis 140:974-980, 1989.
54. Waxman K, Daughters K, Aswani S, et al: Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock. Crit Care Med 74:1724-1728, 1996.
55. Pardo A, Bartoli R, Lorenzo-Zuniga V, et al: Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 31: 858-863, 2000.